Ionis Pharmaceuticals (IONS) Times Interest Earned (2009 - 2026)
Ionis Pharmaceuticals (IONS) posted quarterly Times Interest Earned of -$6.16 for Q2 2026, down 137.9% year-over-year from $16.26 in Q2 2025, and up 7.64% quarter-over-quarter from -$6.67 in Q1 2026.
Powered by 
Analysis
Ionis Pharmaceuticals (IONS) Times Interest Earned (2009 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Times Interest Earned history runs 18 years deep, the most recent figure standing at -$6.16 for Q2 2026.
- In Q2 2026, Times Interest Earned fell 137.9% year-over-year to -$6.16; the TTM figure through Jun 2026 stood at -$35.8 (down 15.53% YoY), while the FY2025 annual figure was -$0.31, up 26.62% from the prior year.
- Times Interest Earned for Q2 2026 stood at -$6.16, up from -$6.67 in the prior quarter.
- The five-year high for Times Interest Earned was $16.26 in Q2 2025, with the low at -$39.84 in Q4 2025.
- The 5-year median for Times Interest Earned is -$5.98 (2024), against an average of -$9.16.
- The sharpest annual moves came in 2024 and 2025: Times Interest Earned sank 658.34% in 2024, then soared 380.43% in 2025.
- Ionis Pharmaceuticals' Times Interest Earned stood at -$35.15 in 2022, then surged by 110.95% to $3.85 in 2023, then plunged by 658.34% to -$21.5 in 2024, then tumbled by 85.32% to -$39.84 in 2025, then surged by 84.53% to -$6.16 in 2026.
- Business Quant data shows IONS's Times Interest Earned at -$6.16 in Q2 2026, -$6.67 in Q1 2026, and -$39.84 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Ionis Pharmaceuticals | 9.60 Bn | 7.55 Bn | 265.21 Mn | -22.15 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -22.15 |
| Mar 31, 2026 | -22.76 |
| Dec 31, 2025 | -44.42 |
| Sep 30, 2025 | -38.03 |
| Jun 30, 2025 | 33.99 |
| Mar 31, 2025 | -35.75 |
| Dec 31, 2024 | -26.44 |
| Sep 30, 2024 | -35.73 |
| Jun 30, 2024 | -14.72 |
| Mar 31, 2024 | -36.02 |
| Dec 31, 2023 | -1.34 |
| Sep 30, 2023 | -34.09 |
| Jun 30, 2023 | -39.37 |
| Mar 31, 2023 | -70.99 |
| Dec 31, 2022 | -120.17 |
| Sep 30, 2022 | -27.65 |
| Jun 30, 2022 | -40.15 |
| Mar 31, 2022 | -27.10 |
| Dec 31, 2021 | 98.57 |
| Sep 30, 2021 | -36.69 |